| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $52.5B | $47.7B | $42.3B | $39.4B | $38.5B | $37.9B | $39.4B | $36.2B |
| Cost of Revenue | — | — | — | — | — | — | $32.3B | $29.5B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $5.4B | $4.8B | $4.2B | $4.2B | $4.2B | $4.1B | $4.6B | $4.5B |
| Net Income | $4.2B | $3.8B | $3.3B | $3.4B | $3.3B | $3.2B | $3.5B | $3.3B |
| EPS (Basic) | $15.65 | $13.81 | $12.14 | $12.31 | $11.61 | $11.04 | $12.09 | $11.33 |
| EPS (Diluted) | $15.45 | $13.63 | $12.02 | $12.19 | $11.55 | $11.00 | $11.98 | $11.18 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $57.2B | $55.9B | $54.8B | $51.6B | $50.1B | $51.3B | $48.8B | $45.4B |
| Current Assets | $24.2B | $24.4B | $23.6B | $21.1B | $20.0B | $21.5B | $19.8B | $18.2B |
| Cash & Equivalents | $2.3B | $1.7B | $1.9B | $1.2B | $1.6B | $2.8B | $0.9B | $1.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $16.8B | $17.8B | $16.4B | $15.3B | $14.0B | $16.0B | $16.8B | $14.7B |
| Stockholders' Equity | $25.6B | $22.1B | $21.3B | $18.6B | $17.6B | $15.7B | $13.6B | $11.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.1B | $4.1B | $4.7B | $4.6B | $4.3B | $3.9B | $3.0B | — |
| Investing Cash Flow | $-1.3B | $-1.0B | $-0.9B | $-1.5B | $-0.9B | $-1.0B | $-1.0B | — |
| Capital Expenditures | $1.2B | $0.9B | $0.9B | $1.1B | $0.9B | $1.0B | $1.0B | $0.7B |
| Financing Cash Flow | $-3.2B | $-3.4B | $-3.1B | $-3.5B | $-4.6B | $-0.9B | $-2.0B | — |